Pharmaceuticals

Revenue of the Spray-Dried Biologics Market Predicted to Achieve $3.2 Billion by 2030, Driven by 11.4% CAGR

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the spray-dried biologics market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Spray-Dried Biologics Market?

The spray-dried biologics market has experienced substantial growth in recent times. Projections indicate its expansion from $1.86 billion in 2025 to $2.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. This historical expansion is attributable to several key factors, including advancements in biologics formulation science, a rise in biologic drug approvals, the necessity for enhanced drug stability, the enlargement of vaccine manufacturing capacity, and the integration of advanced pharmaceutical processing technologies.

The spray-dried biologics market is poised for substantial growth over the next few years, with its valuation expected to reach $3.2 billion by 2030, advancing at a compound annual growth rate (CAGR) of 11.4%. This anticipated expansion during the forecast period is driven by factors such as an escalating demand for non-injectable biologics, increasing investments in dry powder delivery systems, the enlargement of global vaccine production, a heightened focus on reducing cold-chain dependency, and advancements in the design of spray-drying equipment. Significant trends for this period encompass the growing integration of spray-drying for improving biologic stability, a rising need for inhalable and oral biologic formulations, the broadening application of continuous spray-drying processes, an increasing utilization of dry powder biologics in vaccine development, and a more intense focus on extending product shelf-life.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30401&type=smp

Which Drivers Are Supporting The Rise Of The Spray-Dried Biologics Market?

The spray-dried biologics market is anticipated to expand due to the increasing demand for biopharmaceuticals. Biopharmaceuticals are therapeutic products derived from biological sources, including living cells, proteins, and other biomolecules. The global rise in chronic and complex health conditions is fueling this demand, necessitating therapies that provide higher specificity, improved efficacy, and fewer systemic side effects. Consequently, the spray-dried biologics industry is experiencing growing demand, as the rapid expansion of biopharmaceuticals prompts companies to adopt scalable formulation technologies that enhance stability, extend shelf life, and optimize delivery efficiency. For instance, in February 2025, according to the World Health Organization (WHO), a Switzerland-based international public health agency, its 2023 essential medicines list (EML) included 81 biologic therapies, accounting for more than 15% of all essential medicines. Therefore, the escalating demand for biopharmaceuticals is driving the growth of the spray-dried biologics market.

What Segments Are Identified Within The Structure Of The Spray-Dried Biologics Market?

The spray-dried biologics market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types

2) By Route Of Administration: Oral, Inhalation Or Pulmonary, Injectable, Topical

3) By End-User: Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments

2) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines

3) By Enzymes: Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes

4) By Hormones: Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones

5) By Other Product Types: Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins

Which Trends Are Guiding The Evolution Of The Spray-Dried Biologics Market?

Companies in the spray-dried biologics market are prioritizing the adoption of technological advancements, such as drum dosing technology, to improve dose accuracy, enhance powder handling efficiency, and enable reliable large-scale capsule filling. Drum dosing technology is an advanced method for powder filling that utilizes a rotating drum equipped with precision-engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules. This facilitates capabilities like consistent low-dose filling, improved flow management for spray-dried powders, and high-throughput scalability. For instance, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), upgraded its inhalation manufacturing facility in the US. This upgrade included potent capsule-filling capabilities powered by drum-based dosing systems and in-line advanced mass verification. The enhanced platform supports the accurate filling of engineered and spray-dried powders, featuring real-time dose validation and controlled low-humidity processing. This improvement contributes to greater manufacturing efficiency, enhanced product consistency, and readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

Which Leading Companies Dominate The Spray-Dried Biologics Market Share?

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BÜCHI Labortechnik AG.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-spray-dried-biologics-market-report

How Does The Spray-Dried Biologics Market Perform Across Major Global Regions?

North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Spray-Dried Biologics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30401&type=smp

Browse Through More Reports Similar to the Global Spray-Dried Biologics Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Spray Drying Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Agricultural Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/agricultural-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795